Results of Operations and Financial Condition

Business Context and Reporting Period

Trulieve Cannabis Corp. filed this Form 8-K on March 30, 2022, under Items 2.02, 7.01, and 9.01. The filing announced results for the fourth fiscal quarter and year ended December 31, 2021, and furnished a related press release and corporate presentation.

The company is incorporated in British Columbia and maintains its principal executive offices in Quincy, Florida. The filing identifies Trulieve as an emerging growth company.

Financial Results and Key Metrics

  • The filing states that fourth-quarter and full-year 2021 results were announced.
  • The filing text provided does not include clear values for revenue, net income or loss, cash flow, margins, debt, liquidity, or other financial metrics.
  • Detailed results may be contained in Exhibit 99.1, the press release, which is referenced but not included in the supplied filing text.

Material Changes Versus Prior Period

The supplied filing text does not provide quantitative or qualitative comparisons with the prior comparable quarter or year.

Guidance, Outlook, Risks, and Unusual Items

  • The filing does not provide clear guidance, financial outlook, or management commentary in the supplied text.
  • The company furnished a corporate presentation dated March 30, 2022 for use at industry and other conferences.
  • Trulieve disclaimed any obligation to correct or update the corporate presentation.
  • The press release and corporate presentation were furnished, not filed, and generally are not subject to Section 18 liability or incorporated by reference into other filings except by specific reference.

Investor Verification Items

  • Review Exhibit 99.1 for fourth-quarter and full-year 2021 revenue, profitability, cash flow, margins, balance-sheet liquidity, and debt metrics.
  • Review Exhibit 99.2 for operating footprint, strategic priorities, outlook, and any non-GAAP measures or forward-looking statements.
  • Verify the company’s definitions and reconciliations for any non-GAAP financial measures.
  • Assess the risks and contingencies disclosed in the company’s broader periodic filings, which are not reproduced in this 8-K text.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.